Prelude Capital Management, LLC Novartis Ag Transaction History

Prelude Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $53,009 - $59,670	-655 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $763,236 - $1.07 Million	-10,800 Reduced 94.28%	655 $54,000
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $1.54 Million - $1.74 Million	-18,201 Reduced 61.37%	11,455 $1.09 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $883,537 - $1.09 Million	11,718 Added 65.33%	29,656 $2.71 Million
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $110,720 - $126,640	1,470 Added 8.93%	17,938 $1.73 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $990,727 - $1.1 Million	13,450 Added 445.66%	16,468 $1.41 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $884,210 - $1.02 Million	-13,209 Reduced 81.4%	3,018 $260,000
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $246,593 - $278,694	3,799 Added 30.57%	16,227 $1.23 Million
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $874,806 - $1.05 Million	12,428 New	12,428 $1.01 Million
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $509,854 - $547,284	-7,049 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $522,612 - $544,676	7,049	7,049 $605,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.